Positive preclinical test for Transition's diabetes drug
20th Sep 2005, 02:02 GMT
A preclinical test of Transition Therapeutics' investigational drug for the treatment of type 1 diabetes has yielded data that suggests the drug may be effective in treating the disease.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol